Literature DB >> 6953410

Nerve growth factor: activation of the classical complement pathway by specific substitution for component C1-.

M D Boyle, M Young.   

Abstract

The interaction of homogeneous preparations of mouse submandibular gland nerve growth factor (NGF) with the classical complement pathway was studied. NGF was found to be capable of carrying out the enzyme activities of the first component (C1-) of the classical complement pathway (i.e., the cleavage of zymogen C4 and C2). NGF would not substitute for any other classical pathway component, C2-C9. The C1(-)-like activity of NGF was inhibited by human C1- inactivator. This interaction of NGF with the complement system may account for the previously described ability of NGF to accelerate the rate of contraction of experimentally induced wounds.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6953410      PMCID: PMC346230          DOI: 10.1073/pnas.79.8.2519

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Secretion of a nerve growth factor by primary chick fibroblast cultures.

Authors:  M Young; J Oger; M H Blanchard; H Asdourian; H Amos; B G Arnason
Journal:  Science       Date:  1975-01-31       Impact factor: 47.728

2.  Assay and properties of serum inhibitor of C'l-esterase.

Authors:  L R LEVY; I H LEPOW
Journal:  Proc Soc Exp Biol Med       Date:  1959 Aug-Sep

3.  Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

4.  Enzymatic activities of mouse nerve growth factor and its subunits.

Authors:  L A Greene; E M Shooter; S Varon
Journal:  Proc Natl Acad Sci U S A       Date:  1968-08       Impact factor: 11.205

5.  Nerve growth factor: multiple dissociation products in homogenates of the mouse submandibular gland. Purification and molecular properties of the intact undissociated form of the protein.

Authors:  M Young; J D Saide; R A Murphy
Journal:  Biochemistry       Date:  1978-04-18       Impact factor: 3.162

6.  alpha-Adrenergic regulation of secretion of mouse saliva rich in nerve growth factor.

Authors:  L J Wallace; L M Partlow
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

7.  Nerve growth factor: acceleration of the rate of wound healing in mice.

Authors:  A K Li; M J Koroly; M E Schattenkerk; R A Malt; M Young
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

8.  Interaction between components of the human classical complement pathway and immobilized Cibacron Blue F3GA.

Authors:  A P Gee; T Borsos; M D Boyle
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

9.  Molecular properties of the nerve growth factor secreted in mouse saliva.

Authors:  R A Murphy; J D Saide; M H Blanchard; M Young
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

10.  Nerve growth factor in mouse serum and saliva: role of the submandibular gland.

Authors:  R A Murphy; J D Saide; M H Blanchard; M Young
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

View more
  4 in total

1.  Nerve growth factor. A structural relationship between its proteolytic and leukocyte-chemotactic active sites.

Authors:  M Young; A P Gee; M D Boyle; M J Lawman; K L Munger
Journal:  Mol Cell Biochem       Date:  1985-02       Impact factor: 3.396

2.  Fc-mediated binding of IgG to vimentin-type intermediate filaments in vascular endothelial cells.

Authors:  G K Hansson; G A Starkebaum; E P Benditt; S M Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

3.  Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro.

Authors:  A P Gee; M D Boyle; K L Munger; M J Lawman; M Young
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

Review 4.  The first component of human complement (C1): activation and control.

Authors:  R J Ziccardi
Journal:  Springer Semin Immunopathol       Date:  1983
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.